β-Catenin is required for Ron receptor-induced mammary tumorigenesis

scientific article

β-Catenin is required for Ron receptor-induced mammary tumorigenesis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/ONC.2011.86
P8608Fatcat IDrelease_qqhi5pbkjvdijnb3smxrumn37m
P932PMC publication ID3134560
P698PubMed publication ID21423209
P5875ResearchGate publication ID50596741

P2093author name stringL James
S P Monga
P K Wagh
S E Waltz
G M Zinser
J K Gray
J Vasiliauskas
P2860cites workEpidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancerQ24304061
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progressionQ24633875
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nucleiQ27860728
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skinQ28190343
Balancing cell adhesion and Wnt signaling, the key role of beta-cateninQ28288763
Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactionsQ28577530
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancerQ29547699
Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family memberQ33257955
The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cellsQ33592512
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical SignificanceQ33903965
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayQ33969327
Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell linesQ34041328
Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiationQ35588886
Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progressionQ35679187
The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humansQ35758261
beta-Catenin signaling in biological control and cancer.Q36939963
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.Q37293205
The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesisQ37308684
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation.Q37351482
Key signalling nodes in mammary gland development and cancer: Myc.Q37467223
Targeting Wnt signaling: can we safely eradicate cancer stem cells?Q37763415
A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma.Q40006287
A physiologic imaging pilot study of breast cancer treated with AZD2171.Q40333245
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.Q40443024
Overexpression of the RON gene in human breast carcinomaQ41023826
Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female miceQ41400379
Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasisQ42824776
Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancerQ45285566
beta-Catenin and met deregulation in childhood HepatoblastomasQ46741023
Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.Q52537297
Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activationQ57100119
Growth factor expression in Breast tissueQ57581209
Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in miceQ79152321
Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcomeQ82536206
beta-catenin gene mutation in invasive ductal breast cancerQ83189139
P433issue34
P407language of work or nameEnglishQ1860
P304page(s)3694-3704
P577publication date2011-03-21
P1433published inOncogeneQ1568657
P1476titleβ-Catenin is required for Ron receptor-induced mammary tumorigenesis
P478volume30

Reverse relations

cites work (P2860)
Q39289235CBP/Catenin antagonists: Targeting LSCs' Achilles heel
Q36188917CD151 represses mammary gland development by maintaining the niches of progenitor cells.
Q35591995Can we safely target the WNT pathway?
Q37109753Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Q38980169Collective cell migration of primary zebrafish keratocytes
Q35986081Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.
Q47403872Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.
Q35777328Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice
Q37708952FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
Q90835372Generation of novel affibody molecules targeting the EBV LMP2A N-terminal domain with inhibiting effects on the proliferation of nasopharyngeal carcinoma cells
Q36232073HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
Q41708922HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.
Q35025393Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition
Q38786359Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation.
Q38116308MSP-RON signalling in cancer: pathogenesis and therapeutic potential
Q58089109Macrophage Stimulating Protein (MSP) Preserves Blood Brain Barrier Integrity After Intracerebral Hemorrhage Through RON Dependent GAB1/Src/β-catenin Pathway Activation in a Mouse Model
Q52938678Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
Q26864275Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addiction
Q64941091RON and RONΔ160 promote gastric cancer cell proliferation, migration, and adaption to hypoxia via interaction with β-catenin.
Q36206487RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.
Q35577352Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia
Q33764576Ron receptor signaling is protective against DSS-induced colitis in mice.
Q27003295Ron receptor tyrosine kinase signaling as a therapeutic target
Q38224211Safely targeting cancer stem cells via selective catenin coactivator antagonism
Q47138564Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.
Q33836444Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma
Q34765982The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers
Q36887780The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma
Q35190869The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.
Q91673432Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer
Q58777826Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation
Q36140785Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Q36329477Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling